Safety recommendation
HSIB recommends that the National Institute for Health and Care Excellence evaluates the available research relating to the risks associated with menopause on mental health and if appropriate, updates existing guidance.
Response:
The National Institute for Health and Care Excellence (NICE) is currently reviewing the available evidence on the risks associated with menopause on mental health to see if an update to its guideline on the diagnosis and management of menopause [NG23] is required. NICE will then update its recommendations if the review concludes this is necessary.
Actions planned to deliver safety recommendation:
- Undertake an exceptional review of the NICE guideline on menopause: diagnosis and management [NG23], by October 2023.
- Update NG23 if the exceptional surveillance review indicates this is required, by: TBC. Other dependencies identified: An update is dependent on the outcome of the exceptional surveillance review.
Response received on 13 June 2023.